Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes
China Manufacturing PMI Rebounds in December, Offering Boost to Economic Growth Outlook
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
South Korea Exports Hit Record High as Global Trade Momentum Builds
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices
U.S. Dollar Slides Toward Biggest Annual Loss Since 2017 as 2026 Risks Loom
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification
U.S. Dollar Starts 2026 Weak as Yen, Euro and Sterling Hold Firm Amid Rate Cut Expectations 



